These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10500800)

  • 1. CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients.
    Baryshnikov AYu ; Polosukhina ER; Tupitsin NN; Gavrikova NV; Andreeva LYu ; Zabotina TN; Mayakova SA; Kurmashov VI; Syrkin AB; Kadagidze ZG; Blochin DYu ; Shishkin YuV
    Adv Exp Med Biol; 1999; 457():251-8. PubMed ID: 10500800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
    Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
    Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression of variant Fas molecules in acute leukemia cells.
    Inaba H; Komada Y; Li QS; Zhang XL; Tanaka S; Azuma E; Yamamoto H; Sakurai M
    Am J Hematol; 1999 Nov; 62(3):150-8. PubMed ID: 10539881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].
    Polosukhina ER; Kuznetsov SV; Logcheva NP; Zabotina TN; Tenuta MR; Shirin AD; Kaletin GI; Turkina AG; Tsvetaeva NV; Shishkin IuV; Kadagidze ZG; Khoroshko ND; Volkova MA; Baryshnikov AIu
    Ter Arkh; 1998; 70(7):21-5. PubMed ID: 9742630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.
    Putti MC; Rondelli R; Cocito MG; Aricó M; Sainati L; Conter V; Guglielmi C; Cantú-Rajnoldi A; Consolini R; Pession A; Zanesco L; Masera G; Biondi A; Basso G
    Blood; 1998 Aug; 92(3):795-801. PubMed ID: 9680347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of Fas receptor and soluble Fas ligand (sFasL) concentration in acute leukemia].
    Urbaniak-Kujda D; Jaźwiec B; Tomaszewska-Toporska B; Wołowiec D; Kapelko-Słowik K; Kuliczkowski K
    Pol Arch Med Wewn; 2002 Sep; 108(3):873-8. PubMed ID: 12600184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
    Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
    Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
    Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
    Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
    J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolor flow-cytometric, morphologic, and clonogenic analysis of marrow CD10-positive cells in children with leukemia in remission or nonmalignant diseases.
    Fukushima T; Sumazaki R; Koike K; Tsuchida M; Matsui A; Nakauchi H
    J Pediatr Hematol Oncol; 1998; 20(3):222-8. PubMed ID: 9628433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
    Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
    Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD15 as predictor of relapse in children with acute lymphoblastic leukemia of the pre-B type.
    Lenkei R; Björk O; Ost A; Biberfeld P
    Leuk Res; 1991; 15(4):189-94. PubMed ID: 1674292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of antigenic profile of blasts in acute lymphoblastic leukemia: flow cytometric analysis of 152 cases].
    Jmili NB; Souguir S; Yacoub S; Khelif A; Kortas M
    Ann Biol Clin (Paris); 2009; 67(5):543-51. PubMed ID: 19789126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
    Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
    Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.